If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
From the Editor
Publishing Director: Jon Fellows
Operations Director: Andrew Stevens
Head of Production: Charles Dragazis
Editor: Dr Andrew Warmington
E editor@specchemonline.com
US editor: Gregory Morris
E gdlm@enterpriseandindustry.com
Europe editor: Vanessa Zainzinger
E vanessa.zainzinger@gmail.com
Asia editor: Sunny Lee
E sunmail.lee@gmail.com
Project Manager: Steph Cotter
Design: Mark Chambers
Global Commercial Manager:
Jon Williams
E jon@specchemonline.com
Japan and South Korea Agent:
(Mizo) Sadao Mizoguchi
E mijinc7@ybb.ne.jp
From the Editor Publishing Director: Jon Fe
More power to you CMOs continue to invest
P company strategy “to offer a continuum of
The aisles at CPhI Worldwide 2019 in Frankfurt
High potency
£ Poor perception of hazards and risks. The r
P control & containment £ Freque
High potency lab at SK Pharmteco of limited val
Qualification of a small-scale facility for
Figure 2 – Isolator SMEPAC qualification substance
Lonza carries out ADC production at its main
What will bring the breakthrough? CEOs se
Holmgren – We are all behind the curve “You hav
P the marketing clout or skill of a P&G, ye
on, capital. There’s a lot of money available out
Biotech breakthroughs Biotechnology is now
Unlike much higher-volume monomers, like capro
Figure 1 – Petrochemical &
Gene editing & regulatory compliance in Eu
The UN's 17 Sustainable Development Goals £ Agric
P advantages of the biobased society escape
Mesoporous silica One size does not fit all L
P speaking, has the potential to impa
P Substances included in the Candidate List are
Poison centre not
P which mu
Chemical round-up in Texas Specialty & Custom
A growing bubble Europe's premier surfactants